Last Updated:
4:10 pm
Monday, June 23, 2025
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs. The company was founded by Paul John Rennie on May 2, 2014 and is headquartered in Melbourne, Australia.
asx-par
Market Cap
AU$114.88M
Volume
421213
Open
0.30
AU$
High
0.30
AU$
Low
0.29
AU$
Shares On Issue
354M
52 Week Low
0.165
AU$
52 Week High
0.66
AU$
Website
www.paradigmbiopharma.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
No items found.
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved